Special Edition #2: Biopharma And The Management Of Wall St. During A Pandemic
Source: Life Science Leader
Three CEOs of publicly traded biopharmaceutical companies discuss how they are leading their organizations, while also managing the expectations of Wall St. during the COVID-19 pandemic.
This website uses cookies to ensure you get the best experience on our website. Learn more